Aberdeen Group
KRYS icon

Aberdeen Group’s Krystal Biotech KRYS Stock Holding History

Aberdeen Group’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.79M Sell
30,155
-9,205
-23% -$2.45M 0.01% 629
2025
Q4 		$9.7M Sell
39,360
-20,012
-34% -$4.21M 0.02% 616
2025
Q3 		$10.5M Sell
59,372
-49,146
-45% -$7.36M 0.02% 594
2025
Q2 		$14.9M Buy
108,518
+71,217
+191% +$10.5M 0.03% 495
2025
Q1 		$6.73M Sell
37,301
-19,732
-35% -$3.32M 0.01% 645
2024
Q4 		$8.93M Buy
57,033
+13,979
+32% +$2.48M 0.02% 532
2024
Q3 		$7.84M Sell
43,054
-318
-0.7% -$61.3K 0.01% 566
2024
Q2 		$7.96M Buy
43,372
+4,348
+11% +$730K 0.02% 550
2024
Q1 		$6.94M Buy
+39,024
New +$5.42M 0.01% 608

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return